title: Lenalidomide is active for extramedullary disease in refractory multiple myeloma.
authors.forename: Tomonori
authors.initials: T
authors.lastname: Nakazato
authors.forename: Ai
authors.initials: A
authors.lastname: Mihara
authors.forename: Chisako
authors.initials: C
authors.lastname: Ito
authors.forename: Yukinari
authors.initials: Y
authors.lastname: Sanada
authors.forename: Yoshinobu
authors.initials: Y
authors.lastname: Aisa
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D010954:Plasmacytoma / Q000188:drug therapy / Q000473:pathology; D023981:Sarcoma, Myeloid / Q000188:drug therapy* / Q000473:pathology; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide